Symbols / RPRX Stock $50.09 +1.21% Royalty Pharma plc

Healthcare • Biotechnology • United States • NMS
RPRX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Pablo Legorreta
Exch · Country NMS · United States
Market Cap 29.69B
Enterprise Value 33.03B
Income 770.95M
Sales 2.38B
FCF (ttm) -670.41M
Book/sh 15.11
Cash/sh 1.49
Employees 100
Insider 10d —
IPO Jun 16, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 49.44%
P/E 28.14
Forward P/E 9.06
PEG 2.84
P/S 12.49
P/B 3.32
P/C —
EV/EBITDA 21.13
EV/Sales 13.89
Quick Ratio 2.39
Current Ratio 2.40
Debt/Eq 92.33
LT Debt/Eq —
EPS (ttm) 1.78
EPS next Y 5.53
EPS Growth 9.00%
Revenue Growth 4.80%
EPS Gr Q/Q 2.90%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-11
ROA 5.15%
ROE 13.20%
ROIC —
Gross Margin 112.44%
Oper. Margin 57.68%
Profit Margin 32.42%
Shs Outstand 444.38M
Shs Float 420.22M
Insider Own 7.12%
Instit Own 84.91%
Short Float 2.74%
Short Ratio 3.77
Short Interest 12.01M
52W High 50.47
vs 52W High -0.75%
52W Low 31.97
vs 52W Low 56.68%
Beta 0.39
Impl. Vol. 0.20%
Rel Volume 1.16
Avg Volume 3.41M
Volume 3.95M
Target (mean) $52.44
Tgt Median $51.00
Tgt Low $46.00
Tgt High $63.00
# Analysts 9
Recom Buy
Prev Close $49.49
Price $50.09
Change 1.21%
About

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$52.44
Mean price target
2. Current target
$50.09
Latest analyst target
3. DCF / Fair value
$-27.16
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$50.09
Low
$46.00
High
$63.00
Mean
$52.44

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-21 main UBS Buy → Buy $57
2026-04-10 main Morgan Stanley Overweight → Overweight $63
2026-01-30 up UBS Neutral → Buy $49
2026-01-27 main Citigroup Buy → Buy $50
2025-12-11 main TD Cowen Buy → Buy $45
2025-10-10 main Morgan Stanley Overweight → Overweight $54
2025-09-30 init Goldman Sachs — → Buy $42
2025-07-22 main Citigroup Buy → Buy $42
2025-07-10 main Morgan Stanley Overweight → Overweight $54
2024-10-25 main Citigroup Buy → Buy $40
2024-08-14 main Goldman Sachs Buy → Buy $51
2024-07-11 main Morgan Stanley Overweight → Overweight $51
2024-06-03 down UBS Buy → Neutral $28
2024-04-12 main B of A Securities Buy → Buy $38
2024-02-20 main JP Morgan Overweight → Overweight $42
2024-02-20 main Goldman Sachs Buy → Buy $50
2023-11-09 main Morgan Stanley Overweight → Overweight $57
2023-10-11 main Morgan Stanley Overweight → Overweight $54
2023-08-09 main Morgan Stanley Overweight → Overweight $53
2023-07-11 reit Morgan Stanley Overweight → Overweight $52
News
RSS: Latest RPRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 COYNE TERRANCE P Chief Financial Officer — 34,791 $48.33 $1,681,512
2026-03-31 BASSLER BONNIE L Director — 815 $45.98 $37,471
2026-03-23 COYNE TERRANCE P Chief Financial Officer — 34,791 $45.53 $1,583,989
2026-03-02 COYNE TERRANCE P Chief Financial Officer — 34,791 $46.67 $1,627,534
2026-02-23 COYNE TERRANCE P Chief Financial Officer — 34,791 $45.32 $1,576,606
2026-02-11 LEGORRETA PABLO G Chief Executive Officer — 157,828 $0.00 $0
2026-02-11 HITE CHRISTOPHER D. Officer — 26,626 $0.00 $0
2026-02-11 COYNE TERRANCE P Chief Financial Officer — 26,626 $0.00 $0
2026-02-11 URIST MARSHALL J. Officer — 19,970 $0.00 $0
2026-02-04 COYNE TERRANCE P Chief Financial Officer — 243,541 $42.08 $10,360,814
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,378.19
+5.06%
2,263.58
-3.86%
2,354.55
+5.24%
2,237.22
Operating Revenue
2,378.19
+5.06%
2,263.58
-3.86%
2,354.55
+5.24%
2,237.22
Operating Expense
818.67
-15.70%
971.13
+12.61%
862.40
-34.38%
1,314.32
Research And Development
452.00
+22500.00%
2.00
-96.15%
52.00
-70.64%
177.11
Selling General And Administration
573.48
+142.31%
236.67
-5.24%
249.75
+9.87%
227.30
General And Administrative Expense
573.48
+142.31%
236.67
-5.24%
249.75
+9.87%
227.30
Other Gand A
573.48
+142.31%
236.67
-5.24%
249.75
+9.87%
227.30
Other Operating Expenses
-295.84
-140.39%
732.46
+30.64%
560.66
-38.00%
904.24
Total Expenses
818.67
-15.70%
971.13
+12.61%
862.40
-34.38%
1,314.32
Operating Income
1,559.52
+20.66%
1,292.44
-13.38%
1,492.15
+61.68%
922.89
Total Operating Income As Reported
1,559.52
+20.66%
1,292.44
-13.38%
1,492.15
+385.94%
307.06
EBITDA
1,635.71
+5.10%
1,556.33
-17.54%
1,887.28
+345.43%
423.69
Normalized EBITDA
1,611.70
+17.83%
1,367.87
-12.96%
1,571.59
+59.85%
983.17
Reconciled Depreciation
3.85
0.00
0.00
-100.00%
5.67
EBIT
1,631.86
+4.85%
1,556.33
-17.54%
1,887.28
+351.47%
418.02
Total Unusual Items
24.01
-87.26%
188.46
-40.30%
315.69
+156.43%
-559.47
Total Unusual Items Excluding Goodwill
24.01
-87.26%
188.46
-40.30%
315.69
+156.43%
-559.47
Special Income Charges
—
0.00
0.00
+100.00%
-615.83
Write Off
—
0.00
0.00
-100.00%
615.83
Net Income
770.95
-10.25%
858.98
-24.31%
1,134.83
+2549.50%
42.83
Pretax Income
1,324.19
-0.50%
1,330.81
-21.72%
1,700.09
+638.96%
230.06
Net Non Operating Interest Income Expense
-274.07
-53.83%
-178.17
-55.07%
-114.90
-4.81%
-109.63
Interest Expense Non Operating
307.66
+36.43%
225.51
+20.47%
187.19
-0.41%
187.96
Net Interest Income
-274.07
-53.83%
-178.17
-55.07%
-114.90
-4.81%
-109.63
Interest Expense
307.66
+36.43%
225.51
+20.47%
187.19
-0.41%
187.96
Interest Income Non Operating
33.59
-29.05%
47.34
-34.51%
72.29
-7.72%
78.33
Interest Income
33.59
-29.05%
47.34
-34.51%
72.29
-7.72%
78.33
Other Income Expense
38.75
-82.11%
216.54
-32.93%
322.83
+155.36%
-583.20
Other Non Operating Income Expenses
-14.35
-839.07%
-1.53
+92.97%
-21.74
-47.32%
-14.76
Gain On Sale Of Security
24.01
-87.26%
188.46
-40.30%
315.69
+460.20%
56.35
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1,324.19
-0.50%
1,330.81
-21.72%
1,700.09
+638.96%
230.06
Net Income From Continuing Operation Net Minority Interest
770.95
-10.25%
858.98
-24.31%
1,134.83
+2549.50%
42.83
Net Income From Continuing And Discontinued Operation
770.95
-10.25%
858.98
-24.31%
1,134.83
+2549.50%
42.83
Net Income Continuous Operations
1,324.19
-0.50%
1,330.81
-21.72%
1,700.09
+638.96%
230.06
Minority Interests
-553.25
-17.26%
-471.83
+16.53%
-565.25
-201.90%
-187.23
Normalized Income
746.94
+11.40%
670.53
-18.14%
819.14
+36.00%
602.31
Net Income Common Stockholders
770.95
-10.25%
858.98
-24.31%
1,134.83
+2549.50%
42.83
Otherunder Preferred Stock Dividend
—
—
-392.73
—
Diluted EPS
1.78
+23.09%
1.45
-42.84%
2.53
+2430.00%
0.10
Basic EPS
1.79
-7.06%
1.93
-24.17%
2.54
+2440.00%
0.10
Basic Average Shares
429.80
-3.63%
445.99
-0.36%
447.60
+2.20%
437.96
Diluted Average Shares
564.46
-4.97%
594.00
-1.48%
602.90
+37.66%
437.97
Diluted NI Availto Com Stockholders
1,005.52
-11.48%
1,135.88
-25.64%
1,527.56
+3466.40%
42.83
Average Dilution Earnings
234.57
-15.28%
276.89
-29.49%
392.73
—
Amortization
—
0.00
0.00
-100.00%
5.67
Amortization Of Intangibles Income Statement
—
0.00
0.00
-100.00%
5.67
Depreciation Amortization Depletion Income Statement
—
0.00
0.00
-100.00%
5.67
Depreciation And Amortization In Income Statement
—
0.00
0.00
-100.00%
5.67
Earnings From Equity Interest
29.09
-1.76%
29.61
+2.52%
28.88
+421.88%
-8.97
Provision For Doubtful Accounts
89.03
0.00
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
19,620.78
+7.67%
18,222.72
+11.24%
16,381.85
-2.57%
16,813.47
Current Assets
1,528.09
-15.21%
1,802.14
+41.43%
1,274.19
-50.13%
2,554.91
Cash Cash Equivalents And Short Term Investments
1,491.88
-15.76%
1,771.00
+43.55%
1,233.75
-49.18%
2,427.79
Cash And Cash Equivalents
618.70
-33.40%
929.03
+94.76%
477.01
-72.12%
1,710.75
Other Short Term Investments
873.19
+3.71%
841.97
+11.26%
756.74
+5.54%
717.04
Receivables
29.32
+8.76%
26.96
+20.31%
22.41
-38.78%
36.60
Other Receivables
29.32
+8.76%
26.96
+20.31%
22.41
-38.78%
36.60
Other Current Assets
6.89
+64.63%
4.19
-76.79%
18.04
-80.07%
90.52
Total Non Current Assets
18,092.69
+10.18%
16,420.58
+8.69%
15,107.66
+5.96%
14,258.56
Goodwill And Other Intangible Assets
924.63
0.00
—
0.00
Goodwill
924.63
0.00
—
—
Other Intangible Assets
—
—
—
—
Investments And Advances
17,088.76
+4.28%
16,387.04
+8.52%
15,101.14
+6.13%
14,228.93
Long Term Equity Investment
289.97
-23.58%
379.42
+0.94%
375.89
-5.36%
397.18
Other Non Current Assets
79.29
+136.46%
33.53
+414.17%
6.52
-77.99%
29.63
Total Liabilities Net Minority Interest
9,905.84
+25.70%
7,880.35
+25.13%
6,297.56
-13.59%
7,288.09
Current Liabilities
636.21
-49.25%
1,253.62
+676.82%
161.38
-86.17%
1,166.78
Payables And Accrued Expenses
203.05
+8.44%
187.24
+24.83%
150.00
-4.38%
156.87
Payables
92.23
+3.42%
89.18
-9.30%
98.32
-4.27%
102.71
Accounts Payable
19.40
+45.13%
13.37
-11.84%
15.16
+91.82%
7.91
Dividends Payable
72.83
-3.94%
75.81
-8.83%
83.16
-12.29%
94.80
Current Accrued Expenses
110.82
+13.01%
98.06
+89.74%
51.68
-4.58%
54.16
Employee Benefits
577.87
0.00
—
—
Current Debt And Capital Lease Obligation
380.00
-61.92%
997.77
—
997.51
Current Debt
380.00
-61.92%
997.77
—
997.51
Other Current Borrowings
—
997.77
—
997.51
Other Current Liabilities
53.16
-22.50%
68.60
+503.08%
11.38
-8.27%
12.40
Total Non Current Liabilities Net Minority Interest
9,269.63
+39.88%
6,626.73
+7.99%
6,136.19
+0.24%
6,121.31
Long Term Debt And Capital Lease Obligation
8,570.92
+29.57%
6,614.65
+7.81%
6,135.28
+0.27%
6,118.81
Long Term Debt
8,570.92
+29.57%
6,614.65
+7.81%
6,135.28
+0.27%
6,118.81
Other Non Current Liabilities
120.84
+900.36%
12.08
+1242.22%
0.90
-64.00%
2.50
Stockholders Equity
6,476.90
-6.76%
6,946.58
+6.44%
6,526.50
+15.96%
5,628.15
Common Stock Equity
6,476.90
-6.76%
6,946.58
+6.44%
6,526.50
+15.96%
5,628.15
Capital Stock
0.11
-1.85%
0.11
+0.00%
0.11
+0.93%
0.11
Common Stock
0.11
-1.85%
0.11
+0.00%
0.11
+0.93%
0.11
Share Issued
428.67
-3.88%
445.99
-0.16%
446.69
+0.80%
443.17
Ordinary Shares Number
428.67
-3.88%
445.99
-0.16%
446.69
+0.80%
443.17
Additional Paid In Capital
4,123.09
+0.48%
4,103.48
+2.29%
4,011.43
+9.42%
3,666.16
Retained Earnings
2,356.32
-17.20%
2,845.65
+13.03%
2,517.58
+28.14%
1,964.69
Gains Losses Not Affecting Retained Earnings
—
0.00
0.00
0.00
Treasury Stock
2.61
-1.88%
2.66
+1.26%
2.63
-6.31%
2.81
Minority Interest
3,238.04
-4.65%
3,395.78
-4.55%
3,557.79
-8.71%
3,897.22
Other Equity Adjustments
—
—
—
—
Total Equity Gross Minority Interest
9,714.94
-6.07%
10,342.37
+2.56%
10,084.29
+5.87%
9,525.37
Total Capitalization
15,047.82
+10.96%
13,561.23
+7.10%
12,661.78
+7.79%
11,746.96
Working Capital
891.88
+62.60%
548.52
-50.71%
1,112.82
-19.83%
1,388.12
Invested Capital
15,427.82
+5.97%
14,559.01
+14.98%
12,661.78
-0.65%
12,744.47
Total Debt
8,950.92
+17.58%
7,612.43
+24.08%
6,135.28
-13.79%
7,116.32
Net Debt
8,332.22
+24.67%
6,683.40
+18.12%
5,658.27
+4.67%
5,405.57
Net Tangible Assets
5,552.27
-20.07%
6,946.58
+6.44%
6,526.50
+15.96%
5,628.15
Tangible Book Value
5,552.27
-20.07%
6,946.58
+6.44%
6,526.50
+15.96%
5,628.15
Available For Sale Securities
16,798.79
+4.94%
16,007.62
+8.71%
14,725.24
+6.46%
13,831.75
Interest Payable
110.82
+13.01%
98.06
+89.74%
51.68
-4.58%
54.16
Investmentin Financial Assets
16,798.79
+4.94%
16,007.62
+8.71%
14,725.24
+6.46%
13,831.75
Investments In Other Ventures Under Equity Method
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,489.82
-10.08%
2,768.99
-7.32%
2,987.80
+39.36%
2,143.98
Cash Flow From Continuing Operating Activities
2,489.82
-10.08%
2,768.99
-7.32%
2,987.80
+39.36%
2,143.98
Net Income From Continuing Operations
1,324.19
-0.50%
1,330.81
-21.72%
1,700.09
+638.96%
230.06
Depreciation Amortization Depletion
3.85
0.00
0.00
-100.00%
5.67
Depreciation
3.85
0.00
0.00
—
Amortization Cash Flow
—
0.00
0.00
-100.00%
5.67
Depreciation And Amortization
3.85
0.00
0.00
-100.00%
5.67
Amortization Of Intangibles
—
0.00
0.00
-100.00%
5.67
Other Non Cash Items
3,396.69
+13.07%
3,004.08
-7.36%
3,242.82
+30.43%
2,486.26
Stock Based Compensation
289.89
+12267.49%
2.34
-0.55%
2.36
+8.62%
2.17
Provisionand Write Offof Assets
-206.81
-128.23%
732.46
+30.64%
560.66
-38.00%
904.24
Asset Impairment Charge
—
0.00
0.00
-100.00%
615.83
Operating Gains Losses
-2,314.25
+2.25%
-2,367.49
+6.88%
-2,542.32
-17.05%
-2,172.06
Gain Loss On Investment Securities
-2,285.16
+2.25%
-2,337.88
+6.99%
-2,513.44
-15.22%
-2,181.45
Unrealized Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
-17.15
-132.13%
53.38
+891.88%
5.38
-83.52%
32.66
Change In Receivables
-2.36
+48.14%
-4.55
-199.21%
-1.52
+67.94%
-4.74
Change In Payables And Accrued Expense
-4.99
-111.33%
44.09
+1073.86%
3.76
+400.96%
-1.25
Change In Accrued Expense
8.93
-80.74%
46.38
+1970.16%
-2.48
+29.82%
-3.53
Change In Payable
-13.93
-508.21%
-2.29
-136.72%
6.24
+172.79%
2.29
Change In Account Payable
-13.93
-508.21%
-2.29
-136.72%
6.24
+172.79%
2.29
Change In Other Current Assets
-7.45
-153.79%
13.84
+339.91%
3.15
-91.86%
38.65
Change In Other Current Liabilities
-2.35
0.00
0.00
—
Investing Cash Flow
-1,614.18
+39.73%
-2,678.11
-29.20%
-2,072.79
-101.35%
-1,029.42
Cash Flow From Continuing Investing Activities
-1,614.18
+39.73%
-2,678.11
-29.20%
-2,072.79
-101.35%
-1,029.42
Net Investment Purchase And Sale
-1,364.65
+47.87%
-2,617.84
-25.27%
-2,089.69
-104.97%
-1,019.52
Purchase Of Investment
-1,931.16
+29.42%
-2,736.20
-29.34%
-2,115.52
+17.53%
-2,565.07
Sale Of Investment
566.50
+378.62%
118.36
+358.21%
25.83
-98.33%
1,545.54
Net Business Purchase And Sale
-74.42
-579.29%
-10.96
+12.65%
-12.54
-26.74%
-9.90
Purchase Of Business
-74.42
-579.29%
-10.96
+12.65%
-12.54
-26.74%
-9.90
Net Other Investing Changes
-280.26
-284.12%
-72.96
-405.34%
-14.44
—
Financing Cash Flow
-1,185.97
-428.39%
361.14
+116.81%
-2,148.75
-127.42%
-944.86
Cash Flow From Continuing Financing Activities
-1,185.97
-428.39%
361.14
+116.81%
-2,148.75
-127.42%
-944.86
Net Issuance Payments Of Debt
954.48
-35.12%
1,471.23
+247.12%
-1,000.00
0.00
Issuance Of Debt
3,229.47
+119.51%
1,471.23
+320.35%
350.00
0.00
Repayment Of Debt
-2,275.00
0.00
+100.00%
-1,350.00
0.00
Long Term Debt Issuance
3,229.47
+119.51%
1,471.23
+320.35%
350.00
0.00
Long Term Debt Payments
-2,275.00
0.00
+100.00%
-1,350.00
0.00
Net Long Term Debt Issuance
954.48
-35.12%
1,471.23
+247.12%
-1,000.00
0.00
Short Term Debt Issuance
—
—
350.00
0.00
Short Term Debt Payments
—
—
-350.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
-1,227.38
-434.46%
-229.65
+24.65%
-304.76
0.00
Common Stock Payments
-1,227.38
-434.46%
-229.65
+24.65%
-304.76
0.00
Common Stock Dividend Paid
-378.25
-0.47%
-376.46
-5.06%
-358.33
-7.50%
-333.32
Cash Dividends Paid
-378.25
-0.47%
-376.46
-5.06%
-358.33
-7.50%
-333.32
Repurchase Of Capital Stock
-1,227.38
-434.46%
-229.65
+24.65%
-304.76
0.00
Net Other Financing Charges
-534.81
-6.12%
-503.97
-3.77%
-485.67
+20.58%
-611.53
Changes In Cash
-310.33
-168.65%
452.02
+136.64%
-1,233.74
-827.00%
169.70
Beginning Cash Position
929.03
+94.76%
477.01
-72.12%
1,710.75
+11.01%
1,541.05
End Cash Position
618.70
-33.40%
929.03
+94.76%
477.01
-72.12%
1,710.75
Free Cash Flow
2,489.82
-10.08%
2,768.99
-7.32%
2,987.80
+39.36%
2,143.98
Change In Interest Payable
8.93
-80.74%
46.38
+1970.16%
-2.48
+29.82%
-3.53
Common Stock Issuance
—
—
—
0.00
Dividend Received CFO
13.40
+0.00%
13.40
-28.83%
18.82
-51.91%
39.14
Dividends Received CFI
105.15
+344.77%
23.64
-46.13%
43.88
0.00
Earnings Losses From Equity Investments
-29.09
+1.76%
-29.61
-2.52%
-28.88
-421.88%
8.97
Issuance Of Capital Stock
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category